Advanced search
Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 26, 2014 - Issue 2
Submit an article Journal homepage
421
Views
14
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES

Preexposure prophylaxis (PrEP) of HIV infection in France: A nationwide cross-sectional study (PREVIC study)

E. RosenthalDepartment of Internal Medicine, CHU de Nice, Hôpital de l'Archet, Nice, FranceCorrespondence[email protected]
,
L. PirothDepartment of Infectious Diseases, Hôpital du Bocage, Dijon, France
,
E. CuaDepartment of Infectious Diseases, Hôpital de l'Archet, Nice, France
,
A. JouliéDepartment of Internal Medicine, CHU de Nice, Hôpital de l'Archet, Nice, France
,
I. RavauxDivision of Infectious Diseases, Hôpital de la Conception, Marseille, France
,
M. ChauveauDepartment of Infectious Diseases, Hôpital Purpan, Toulouse, France
,
K. LacombeDepartment of Infectious Diseases, Hôpital Saint-Antoine, Paris, France
,
L. CotteDepartment of Infectious Diseases, Hôpital de la Croix-Rousse, Lyon, France
,
P. BonnardDepartment of Infectious Diseases, Hôpital Tenon, Paris, France
,
L. WeissDepartment of Clinical Immunology, Hôpital Européen Georges Pompidou, Paris, France
,
M. LonguetDepartment of Internal Medicine, Hôpital de la Pitié, Pierre et Marie Curie University, Paris, France
,
C. PradierDepartment of Public Health, Hôpital de l'Archet, Nice, France
,
P. CacoubDepartment of Internal Medicine, Hôpital de la Pitié, Pierre et Marie Curie University, Paris, France
& the GERMIVIC Study Group show all
Pages 176-185 | Received 11 May 2012, Accepted 03 May 2013, Published online: 11 Jun 2013

References

  • Abdool Karim, Q., Abdool Karim, S. S., Frohlich, J. A., Grobler, A. C., Baxter, C., Mansoor, L. E., … CAPRISA 004 Trial Group. (2010). Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science, 329, 1168–1174. Epub 2010 Jul 19. Erratum in: Science. 2011 Jul 29; 333(6042), 524. doi:10.1126/science.1193748
  • Aghaizu, A., Mercey, D., Copas, A., Johnson, A. M., Hat, G., & Nardone, A. (2013). Who would use PrEP? Factors associated with intention to use among MSM in London: A community survey. Sexually Transmitted Infections, 89, 207–211. doi:10.1136/sextrans-2012-050648
  • amfAR/AVAC. (2009). Summary of amfAR/AVAC consultation on the intermittent PrEP (iPrEP) research agenda. Retrieved from http://www.amfar.org/uploadedFiles/In_the_community/Publications/iPrep.pdf?n=1138
  • Arnold, E. A., Hazelton, P., Lane, T., Christopoulos, K. A., Galindo, G. R., Steward, W. T., & Morin, S. F. (2012). A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection. PloS One, 7(7), e40603. doi:10.1371/journal.pone.0040603
  • Centers for Disease Control and Preventions [CDC]. (2011). Interim guidance: Preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. Morbidity and Mortality Weekly Report, 60, 65–68.
  • Eisingerich, A. B., Wheelock, A., Gomez, G. B., Garnett, G. P., Dybul, M. R., & Piot, P. K. (2012). Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: A multinational study. PLoS One, 7(1), e28238. doi:10.1371/journal.pone.0028238
  • French Hospital Database on HIV [FHDH]. (2010). FHDH. Retour d'Informations Clinico-Epidémiologiques (RICE) [Feedback on clinical-epidemiological data]. Retrieved from http://www.ccde.fr
  • Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., … iPrEx Study Team. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. The New England Journal of Medicine, 363(27), 2587–2599. doi:10.1056/NEJMoa1011205
  • Hogan, T. P., & Palmer, C. L. (2005). Information preferences and practices among people living with HIV/AIDS: Results from a nationwide survey. Journal of the Medical Library Association, 93, 431–439. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1250318/pdf/i0025-7338-093-04-0431.pdf
  • Kamphuis, H., Hekkert, K., van Dongen, M. C., & Kool, T. (2012). Facts and figures about patient associations in the Netherlands between 2007 and 2009: Review of their activities and aims. Health Policy, 107, 243–248. doi:10.1016/j.healthpol.2012.06.008
  • Korb-Salvodelli, V., Gillaizeau, F., Caruba, T., Tauckoor, A., Progon, P., Durieux, P., & Sabatier, B. (2012, July 26). Information about medication in HIV-infected patients and its relation to adherence. An observational cross-sectional study. Swiss Medical Weekly, 142.
  • Lorente, N., Fugon, L., Carrieri, M. P., Andreo, C., Le Gall, J. M., Cook, E., … Spire, B. (2012). Acceptability of an “on-demand” pre-exposure HIV prophylaxis trial among men who have sex with men living in France. AIDS Care, 24, 468–477. doi:10.1080/9540121.2011.626394
  • McNeil, D. G. (2010, November 23). Daily pill greatly lowers AIDS risk, study findings. The New York Times. Retrieved from http://www.nytimes.com/2010/11/24/health/research/24aids.html?_r=0
  • Microbicide trials network. (2011). Statement on decision to discontinue use of oral Tenofovir tablets in VOICE, a major HIV prevention study in women. Microbicide Trials Network. Retrieved from http:/www.mtnstopshiv.org/node/3619
  • Myers, G. M., & Mayer, K. H. (2011). Oral preexposure anti-HIV prophylaxis for high-risk US populations. Current considerations in light of new findings. AIDS Patients Care STDS, 25(2), 63–71. doi:10.1089/apc.2010.0222
  • Perez, M. (2010, November 24). Sida: les antiviraux réduisent les risques de contamination [AIDS: Antiretroviral drugs decrease the risk of transmission] [Electronic Version]. Le Figaro. Retrieved from http://sante.lefigaro.fr/actualite/2010/11/24/10567-sida-antiviraux-reduisent-risque-contamination?position=42&keyword=sida+contamination
  • Roehr, B. (2011a). HIV prevention trial in women is abandoned after drugs show no impact on infection rates. British Medical Journal, 342, d2613.
  • Roehr, B. (2011b). Tenofovir works as pre-exposure prophylaxis against HIV, two studies confirm. British Medical Journal, 343, d4540. doi:10.1136/bmj.d4540
  • TRT-5. (2010). Projet d'essai de traitement antirétroviral en prophylaxie pré-exposition chez les homosexuals masculins: Rapport de consultation communautaire [Pre-exposure prophylaxis trial project among homosexual men: Community consultation report] [Electronic Version]. Retrived from http://www.trt-5.org/IMG/pdf/TRT-5_-_Rapport_Consultation_communautaire_PrEP_FINAL_.pdf
  • Underhill, K., Operario, D., Mimiaga, M. J., Skeer, M. R., & Mayer, K. H. (2011). Implementation science of pre-exposure prophylaxis: Preparing for public use. Current HIV/AIDS Reports, 7, 210–219. doi:10.1007/s11904-010-0062-4

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Supercharge Your Next Research Paper: Research and write your next paper with Jenni AI.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.